StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Galenica AG
Swiss Stock Exchange:GALE.SW
Sector
Location
Market Cap
USD 5.49 B
Share Price
USD 110.12
Avg Daily Volume
96,322
Change (1 day)
0.24%
Change (1 year)
29.83%
Change (YTD)
33.94%
Galenica AG EBIT for the year ending December 31, 2024: USD 243.93 M
Galenica AG EBIT is USD 243.93 M for the year ending December 31, 2024, a 0.71% change year over year. EBIT means earnings before interest and taxes, it is calculated as operating income plus non-operating income.
-
Galenica AG EBIT for the year ending December 31, 2023 was USD 242.20 M, a 17.33% change year over year.
-
Galenica AG EBIT for the year ending December 31, 2022 was USD 206.42 M, a -6.74% change year over year.
-
Galenica AG EBIT for the year ending December 31, 2021 was USD 221.33 M, a -6.41% change year over year.
-
Galenica AG EBIT for the year ending December 31, 2020 was USD 236.49 M, a 39.76% change year over year.
Competitors
Merck & Co., Inc.
USD 82.43
MRK
+0.91
1.12%
McKesson Corporation
USD 715.74
MCK
+4.92
0.69%
Elevance Health Inc.
USD 344.55
ELV
+8.34
2.48%
Cencora, Inc.
USD 297.83
COR
+3.18
1.08%
BeOne Medicines Ltd.
USD 279.16
ONC
+9.46
3.51%
JD Health International Inc.
USD 5.97
6618.HK
+0.16
2.74%
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
USD 2.33
2196.HK
+0.01
0.22%
Shanghai Pharmaceuticals Holding Co., Ltd
USD 1.58
2607.HK
+0.02
1.47%
Haisco Pharmaceutical Group Co., Ltd.
USD 6.65
002653.SZ
+0.00
0.03%
Sinopharm Group Co. Ltd.
USD 2.37
1099.HK
+0.01
0.43%
Hikma Pharmaceuticals PLC
USD 26.49
HIK.L
-0.15
-0.56%
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
USD 2.29
0874.HK
-0.00
-0.11%
Option Care Health, Inc.
USD 30.39
OPCH
-0.35
-1.16%
Humanwell Healthcare (Group) Co.,Ltd.
USD 3.08
600079.SS
+0.06
2.08%
China Resources Pharmaceutical Group Limited
USD 0.67
3320.HK
-0.00
-0.57%
China Medical System Holdings Limited
USD 1.67
0867.HK
+0.00
0.15%
Kangmei Pharmaceutical Co., Ltd.
USD 0.29
600518.SS
+0.00
0.58%
Amneal Pharmaceuticals, Inc.
USD 8.26
AMRX
-0.01
-0.12%
MediPal Holdings Corporation
USD 16.44
7459.T
+0.17
1.07%
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
USD 5.01
600329.SS
+0.03
0.54%
Key Data
| Date | EBIT | EBITDA | Net Income | EPS (Diluted) |
|---|
Competitors
Merck & Co., Inc.
USD 82.43
MRK
+0.91
1.12%
McKesson Corporation
USD 715.74
MCK
+4.92
0.69%
Elevance Health Inc.
USD 344.55
ELV
+8.34
2.48%
Cencora, Inc.
USD 297.83
COR
+3.18
1.08%
BeOne Medicines Ltd.
USD 279.16
ONC
+9.46
3.51%
JD Health International Inc.
USD 5.97
6618.HK
+0.16
2.74%
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
USD 2.33
2196.HK
+0.01
0.22%
Shanghai Pharmaceuticals Holding Co., Ltd
USD 1.58
2607.HK
+0.02
1.47%
Haisco Pharmaceutical Group Co., Ltd.
USD 6.65
002653.SZ
+0.00
0.03%
Sinopharm Group Co. Ltd.
USD 2.37
1099.HK
+0.01
0.43%
Hikma Pharmaceuticals PLC
USD 26.49
HIK.L
-0.15
-0.56%
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
USD 2.29
0874.HK
-0.00
-0.11%
Option Care Health, Inc.
USD 30.39
OPCH
-0.35
-1.16%
Humanwell Healthcare (Group) Co.,Ltd.
USD 3.08
600079.SS
+0.06
2.08%
China Resources Pharmaceutical Group Limited
USD 0.67
3320.HK
-0.00
-0.57%
China Medical System Holdings Limited
USD 1.67
0867.HK
+0.00
0.15%
Kangmei Pharmaceutical Co., Ltd.
USD 0.29
600518.SS
+0.00
0.58%
Amneal Pharmaceuticals, Inc.
USD 8.26
AMRX
-0.01
-0.12%
MediPal Holdings Corporation
USD 16.44
7459.T
+0.17
1.07%
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
USD 5.01
600329.SS
+0.03
0.54%